Oscar Health, Inc.
OSCR
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 20.07 | -335.84% |
| 2025 | -8.51 | -106.70% |
| 2024 | 127.04 | -1,795.74% |
| 2023 | -7.49 | 768.98% |
| 2022 | -0.86 | -64.86% |
| 2021 | -2.45 | -88.01% |
| 2020 | -20.47 | 425.00% |
| 2019 | -3.90 | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 22.58 | 12.50% |
US
|
|
| 23.60 | 17.59% |
US
|
|
| 19.03 | -5.20% |
US
|
|
| 11.94 | -40.50% |
US
|
|
| 40.15 | 100.04% |
US
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.